SCHEMBL992853

SCHEMBL992853

CC(C)N1CCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106524 0.86 SMN1; SMN2 (0.37)
SCHEMBL13501646 0.84 KDM4E (0.36)
SCHEMBL22635770 0.84
SCHEMBL29237864 0.81 TOP2A (0.36)
SCHEMBL21217110 0.81
SCHEMBL367449 0.81
SCHEMBL10367525 0.81
SCHEMBL7552234 0.81
SCHEMBL530825 0.81
SCHEMBL12419674 0.79 TOP2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367904-B2 Amide-based electrolyte battery BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY (US) 2022-06-21 US claimed
US-20200411908-A1 AMIDE-BASED ELECTROLYTE BATTERY BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2020-12-31 US claimed
US-20180316061-A1 AMIDE-BASED ELECTROLYTE BATTERY BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2018-11-01 US claimed
EP-1745046-B1 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZIOSOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF MEMORY PHARM CORP (US) 2011-04-13 EP claimed
US-20090325939-A1 1H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF XIE WENGE 2009-12-31 US claimed
US-7632831-B2 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2009-12-15 US claimed
CN-101124226-A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof MEMORY PHARM CORP (US) 2008-02-13 CN claimed
EP-1745046-A2 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZIOSOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2007-01-24 EP claimed
US-20050272735-A1 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2005-12-08 US claimed
WO-2005111038-A2 1H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2005-11-24 WO claimed
US-20260125361-A1 TYK2 INHIBITORS AND USES THEREOF ALUMIS INC (US) 2026-05-07 US disclosed
EP-4461734-B1 TYK2 INHIBITORS AND USES THEREOF ALUMIS INC (US) 2026-02-04 EP disclosed
EP-4480953-B1 TYK2 INHIBITORS AND USES THEREOF ALUMIS INC (US) 2026-02-04 EP disclosed
EP-4615832-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS Bristol-Myers Squibb Company (US) 2025-09-17 EP disclosed
US-12351572-B2 Substituted 1,2,4-triazoles as TYK2 inhibitors ALUMIS INC. (US) 2025-07-08 US disclosed
WO-2001023362-A2 RATE-CONTROLLED PARTICLES ABBOTT GMBH & CO. KG (DE) 2001-04-05 WO disclosed
EP-1068200-A1 2,4,4-TRISUBSTITUTED-1,3-DIOXOLANE ANTIFUNGALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-01-17 EP disclosed
WO-1999002523-A1 2,4,4-TRISUBSTITUTED-1,3-DIOXOLANE ANTIFUNGALS JANSSEN PHARMACEUTICA N.V. (BE) 1999-01-21 WO disclosed
US-5422042-A Improved toughness and flexibility HUNTSMAN CORPORATION (US) 1995-06-06 US disclosed
US-5422042-A Improved toughness and flexibility HUNTSMAN CORPORATION (US) 1995-06-06 US disclosed